Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03605589
Title Pembro + Blina Combination in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Leukemia or Lymphoma
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Children's Hospital Medical Center, Cincinnati
Indications

B-cell lymphoma

childhood B-cell acute lymphoblastic leukemia

Therapies

Blinatumomab + Pembrolizumab

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.